Core Viewpoint - Liansheng Chemical has shown a stable performance in terms of financing and stock trading, with significant growth in revenue and net profit year-on-year, indicating a positive outlook for the company. Financing and Trading Summary - On October 13, Liansheng Chemical's stock rose by 0.69%, with a trading volume of 38.83 million yuan. The financing buy-in amount was 5.03 million yuan, while the financing repayment was 3.98 million yuan, resulting in a net financing buy-in of 1.06 million yuan. The total financing and securities balance reached 53.86 million yuan, accounting for 1.89% of the circulating market value, which is above the 90th percentile of the past year, indicating a high level of financing activity [1]. - The company had no short-selling activity on October 13, with both short-selling repayment and sales at 0 shares, leading to a short-selling balance of 0 yuan, also above the 90th percentile of the past year, indicating a lack of short-selling interest [1]. Business Performance Summary - As of June 30, Liansheng Chemical had 8,697 shareholders, an increase of 2.52% from the previous period. The average number of circulating shares per person was 10,779, which increased by 238.68% [2]. - For the first half of 2025, Liansheng Chemical reported a revenue of 343 million yuan, representing a year-on-year growth of 13.95%. The net profit attributable to the parent company was 18.02 million yuan, reflecting a year-on-year increase of 9.61% [2]. Dividend Summary - Since its A-share listing, Liansheng Chemical has distributed a total of 97.52 million yuan in dividends. Over the past three years, the cumulative dividend payout has been 75.38 million yuan [3].
联盛化学10月13日获融资买入503.29万元，融资余额5386.16万元